SCHEMBL3326772

SCHEMBL3326772

COCCC(CC(=O)OC)C1c2ccccc2CC1N

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PYGL P06737 1/20 0.41
ALDH1A1 P00352 3/20 0.34
KDM4E B2RXH2 2/20 0.34
GAA P10253 2/20 0.34
GLA P06280 1/20 0.34
ATM Q13315 1/20 0.34
F2 P00734 1/20 0.34
MTNR1A P48039 1/20 0.33
MTNR1B P49286 1/20 0.33
EGFR P00533 1/20 0.33
PRMT5 O14744 1/20 0.33
MEN1 O00255 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP3A4 P08684 1/20 0.33
ALOX15 P16050 1/20 0.33
TSHR P16473 1/20 0.33
MAPK1 P28482 1/20 0.33
CYP2C19 P33261 1/20 0.33
KMT2A Q03164 1/20 0.33
HPGD P15428 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL3326769 0.99 PYGL (0.40) PYGLALDH1A1KDM4EGAAGLA
SCHEMBL4146405 0.73 TSHR (0.39) ALDH1A1MTNR1AMTNR1BMEN1CYP1A2
Hydrochloric Acid SCHEMBL4146401 0.72 TSHR (0.39) ALDH1A1MTNR1AMTNR1BMEN1CYP1A2
SCHEMBL3326777 0.72 PYGL (0.79) PYGL
SCHEMBL24650853 0.71 EGFR (0.45) F2MTNR1AMTNR1BEGFRMEN1
SCHEMBL4151106 0.71 EGFR (0.45) F2MTNR1AMTNR1BEGFRMEN1
SCHEMBL24650469 0.71 PYGL (0.40) PYGLF2MTNR1AMTNR1BEGFR
Hydrochloric Acid SCHEMBL4151104 0.70 EGFR (0.44) F2EGFR
SCHEMBL3327689 0.70 DRD4 (0.39) PYGLALDH1A1ATMF2MTNR1A
SCHEMBL24650854 0.69 F2 (0.43) PYGLF2MTNR1AMTNR1BEGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100137397-A1 Chemical Compounds ASTRAZENECA AB (SE) 2010-06-03 US disclosed
EP-1848721-A1 CHEMICAL COMPOUNDS AstraZeneca AB (SE) 2007-10-31 EP disclosed
WO-2006082401-A1 CHEMICAL COMPOUNDS ASTRAZENECA AB (SE) 2006-08-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100137397-A1 Chemical Compounds PYGL, PYGM, GYS2 PYGL 1/4885ALDH1A1 604/4885KDM4E 2362/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.